Aveanna Healthcare Holdings Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.43B | — | $2.02B | $1.90B | $1.79B | $1.50B | $1.38B |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | $810.5M | — | $635.5M | $595.4M | $553.2M | $454.5M | $419.3M |
| Gross Margin | 33.3% | — | 31.4% | 31.4% | 30.9% | 30.4% | 30.3% |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $374.5M | — | $352.8M | $361.0M | $357.2M | $240.9M | $227.8M |
| Operating Income | $256.5M | — | $139.8M | $8.1M | $-642.3M | $-3.5M | $39.0M |
| Operating Margin | 10.5% | — | 6.9% | 0.4% | -35.9% | -0.2% | 2.8% |
| Interest Expense | $140.1M | — | $156.6M | $153.2M | $107.7M | $83.0M | $92.3M |
| Pretax Income | $106.9M | — | $5.1M | $-139.0M | $-663.8M | $-51.7M | $-75.0M |
| Income Tax Expense | $-118.1M | — | $16.0M | $-4.5M | $-1.8M | $5.3M | $1.5M |
| Net Income | $225.0M | — | $-10.9M | $-134.5M | $-662.0M | $-57.1M | $-76.5M |
| Net Margin | 9.2% | — | -0.5% | -7.1% | -37.0% | -3.8% | -5.5% |
| EPS (Basic) | $1.11 | — | $-0.06 | $-0.71 | $-3.57 | $-0.40 | $-0.56 |
| EPS (Diluted) | $1.05 | — | $-0.06 | $-0.71 | $-3.57 | $-0.40 | $-0.56 |
| Shares Outstanding (Basic) | 203.5M | 195.1M | 192.9M | 190.0M | 185.6M | 141.9M | — |
| Shares Outstanding (Diluted) | 215.0M | 195.1M | 192.9M | 190.0M | 185.6M | 141.9M | — |
| Dividends Per Share | — | — | — | — | — | — | — |